Email Alert RSS
Volume 1 Issue 2
Oct.  2010
Turn off MathJax
Article Contents
Abstract
References
Related Articles
Shu-fen LIU, Yuan-jie LI, Cheng-jin HUANG, Qi WANG, Wei QIN, Xiao-rong GAI, Ying SHEN, Ling QIU, Xue-jun ZENG. Association between Hyperuricemia and Other Metabolism Dysfunctions[J]. Medical Journal of Peking Union Medical College Hospital, 2010, 1(2): 150-154.
Citation: Shu-fen LIU, Yuan-jie LI, Cheng-jin HUANG, Qi WANG, Wei QIN, Xiao-rong GAI, Ying SHEN, Ling QIU, Xue-jun ZENG. Association between Hyperuricemia and Other Metabolism Dysfunctions[J]. Medical Journal of Peking Union Medical College Hospital, 2010, 1(2): 150-154.
shu

Association between Hyperuricemia and Other Metabolism Dysfunctions

  • 1.

    Department of General Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of MedicalSciences & Peking Union Medical College, Beijing 100730, China

  • 2.

    Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of MedicalSciences & Peking Union Medical College, Beijing 100730, China

  • 3.

    Department of Physical Examination Center, Peking Union Medical College Hospital, Chinese Academy of MedicalSciences & Peking Union Medical College, Beijing 100730, China

  • 4.

    Department of Laboratory Medicine, Peking Union Medical College Hospital, Chinese Academy of MedicalSciences & Peking Union Medical College, Beijing 100730, China

More Information
  • Corresponding author:

    ZENG Xue-jun Tel:010-88068520, E-mail:zxuejun@yahoo.com

  • Received Date: July 25, 2010
  • Issue Publish Date: October 29, 2010
    Graphical Abstract
    • Abstract
  •   Objective  To explore the association between hyperuricemia and other metabolism dysfunctions.
      Methods  A cross-sectional study in 2074 health examination subjects in our hospital in 2008. We calculated the prevalences of hyperuricemia and other metabolism dysfunctions and explored the association between hyperuricemia and other metabolism dysfunctions using bivariate correlation analysis and Logistic multiple analysis.
      Results  The prevalence were as follows:hyperuricemia is 14.27%, obesity 12.07%, hypertension 24.70%, fasting hyperglycaemia 19.46%, hypercholesteremia 36.38%, hypertriglyceridemia 28.68%, fatty liver 40.28%. The prevalences of metabolism dysfunctions were significantly higher in hyperuricemia group than in non-hyperuricemia group, and such significant differences still existed after having been adjusted with age. Bivariate correlation analysis showed that hyperuricemia was significantly correlated with age, gender, body mass index, systolic blood pressure, diastolic blood pressure, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, total cholesterol, triglyceride, non-high-density lipoprotein cholesterol, glucose, creatinine, and fatty liver. Logistic multiple regression analysis showed that the level of serum uric acid was independently associated with obesity, hypertension, low-density lipoprotein cholesterol, hypertriglyceridemia, and fatty liver.
      Conclusions  Hyperuricemia is independently associated with obesity, hypertension, hypertriglyceridemia, and fatty liver. It can increase the risk of these metabolic disorders.
    • FullText(HTML)
    • References (22)
  • [1]
    Zorana JI, Lidija M, Vesna SK, et al.Independent association of high serum uric acid concentration with angiographically defined coronary artery disease[J]. Tokoku J Exp Med, 2007, 211:369-377. DOI: 10.1620/tjem.211.369
    [2]
    Verdecchia P, Schillaci G, Reboldi GP, et al.Relation between serum uric acid and risk of cardiovascular disease in essential hypertension [J]. Hypertension, 2000, 36: 1072-1078. DOI: 10.1161/01.HYP.36.6.1072
    [3]
    Fang J, Alderman MH.Serum uric acid and cardiovascular mortality.The NHANES I epidemiologic follow-up study, 1971-1992 [J]. JAMA, 2000, 283:2404-2410. DOI: 10.1001/jama.283.18.2404
    [4]
    Liese AD, Hense HW, Löwel H, et al.Associationation of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in MONICA Augsburg cohort[J]. Epidemiology, 1999, 10:391-397. DOI: 10.1097/00001648-199907000-00009
    [5]
    张兴平, 陈庆伟, 郑陵.高血压病患者合并高尿酸血症与颈动脉粥样硬化的关系[J].重庆医学, 2004, 33: 35-36. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=cqyx200401015
    [6]
    张立晶, 胡大一, 杨进刚.有心血管疾病危险因素人群中高尿酸血症的发生率及其相关因素[J].首都医科大学学报.2005, 26:124-127. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=sdykdxxb200502007
    [7]
    方圻, 游凯, 林其燧, 等.中国正常人血清尿酸调查及其与血脂的关系[J].中华内科杂志, 1983, 22:434- 438. http://www.cnki.com.cn/Article/CJFDTotal-NTYX198701015.htm
    [8]
    杜蕙, 陈顺乐, 王元, 等.上海市黄浦区社区高尿酸血症与痛风流行病学调查[J].中华风湿病学杂志, 1998, 2:75-78. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhfsbx98199802005
    [9]
    姜宝法, 张源潮, 徐晓菲, 等.山东沿海地区痛风和高尿酸血症的流行病学调查[J].中国公共卫生, 1999, 15:205-206. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=QK199900816181
    [10]
    邵继红, 莫宝庆, 喻荣彬, 等.南京市社区人群高尿酸血症与痛风的流行病学调查[J].疾病控制杂志, 2003, 7:305-308. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=jbkzzz200304014
    [11]
    方卫纲, 黄晓明, 王玉, 等.高尿酸血症在北京地区1997人中的患病情况及相关因素分析[J].中华医学杂志, 2006, 86:1764-1768. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyx200625011
    [12]
    Niskanen L, Laaksonen DE, Lindstr J, et al.Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance[J]. Diabetes Care, 2006, 29: 709-711. DOI: 10.2337/diacare.29.03.06.dc05-1465
    [13]
    Tseng CH.Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan[J]. Kidney Int, 2005, 68:796-801. DOI: 10.1111/j.1523-1755.2005.00459.x
    [14]
    Hovind P, Rossing P, Tarnow L, et al.Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes an inception cohort study[J]. Diabetes, 2009, 58:1668-1671. DOI: 10.2337/db09-0014
    [15]
    Ioachimescu AG, Brennan DM, Hoar BM, et al.Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease[J]. Arthritis Rheum, 2008, 58:623-630. DOI: 10.1002/art.23121
    [16]
    Baker JF, Krishnan E, Chen L, et al.Serum uric acid and cardiovascular disease:recent developments, and where do they leave us? [J]. Am J Med, 2005, 118:816-826. DOI: 10.1016/j.amjmed.2005.03.043
    [17]
    Wannamethee SG.Serum uric acid and risk of coronary heart disease[J]. Curr Pharm Des, 2005, 11:4125-4132. DOI: 10.2174/138161205774913200
    [18]
    Lai SW, Tan CK, Ng KC.Epidemiology of fatty liver in a hospital based study in Taiwan[J]. South Med J, 2009, 95:1288-1292. http://search.ebscohost.com/login.aspx?direct=true&db=aph&AN=9129393&site=ehost-live
    [19]
    Li YM, Xu CF, Yu CH, et al.Association of serum uric acid level with non-alcoholic fatty liver disease:Across-sectional study[J]. JHepatol, 2009, 50:1029-1034. DOI: 10.1016/j.jhep.2008.11.021
    [20]
    Nakagawa T, Hu H, Zharikov S, et al.A causal role for uric acid infructose-induced metabolic syndrome[J]. Am J Physiol Renal Physiol, 2006, 290:625-631. DOI: 10.1152/ajprenal.00140.2005
    [21]
    张浩军, 张冰, 刘小青.小鼠高尿酸高脂血症复合模型初探[J].北京中医药大学学报, 2001, 24:29-30. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=bjzyydxxb200106010
    [22]
    罗荣高, 杨兴仁, 李东升.脂肪肝与血脂的关系探讨[J].临床军医杂志, 2006, 34:30-31. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=lincjyzz200603039
    • Related Articles

  • Related Articles

    [1]DONG Kaixuan, ZHENG Ya, WANG Yuping, GUO Qinghong. Mechanism of SIRT2 in Metabolic Dysfunction-associated Steatotic Liver Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(6): 1382-1388. DOI: 10.12290/xhyxzz.2024-0103
    [2]DONG Kaixuan, CHEN Danni, ZHENG Ya, WANG Yuping, GUO Qinghong. The Role of CEACAM1 in Metabolic Dysfunction-associated Steatotic Liver Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1117-1123. DOI: 10.12290/xhyxzz.2024-0035
    [3]CHEN Danni, WANG Shiling, LU Hong, ZHENG Ya, WANG Yuping, REN Qian. Relationship Between Vitamin D and Metabolic Associated Fatty Liver Disease and Its Mechanism[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1258-1265. DOI: 10.12290/xhyxzz.2023-0075
    [4]HUANG Lu, WU Youbin, NI Yiran, LIU Mengyuan, WU Jiangfeng, ZHANG Yanqiong. The Mechanism of miRNAs in Liver Fibrosis[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1251-1257. DOI: 10.12290/xhyxzz.2023-0125
    [5]CHEN Danni, WANG Shiling, LU Hong, ZHENG Ya, WANG Yuping, REN Qian. Relationship and Potential Mechanism Between Helicobacter Pylori Infection and Non-alcoholic Fatty Liver Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 833-838. DOI: 10.12290/xhyxzz.2022-0710
    [6]YANG Chenlu, ZHAO Xinyu, HU Shiqi, LAN Yanqi, FENG Baoyu, WANG Li. Weight Control and Non-alcoholic Fatty Liver Disease: Evidence from China[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 44-49. DOI: 10.12290/xhyxzz.2022-0691
    [7]Cheng-hao SHAO, Jun-feng PENG. Surgical Treatment of Pancreatic Neuroendocrine Neoplasm with Liver Metastasis[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(4): 383-388. DOI: 10.3969/j.issn.1674-9081.2020.04.005
    [8]Xiao-yan TANG, Meng CHEN, Ming-sheng MA, Ming Li, Zheng-qing QIU. Characteristic Liver Manifestations of Glycogen Storage Disease Type Ⅰa: A Retrospective Study of 82 Cases[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(4): 405-407. DOI: 10.3969/j.issn.1674-9081.2014.04.010
    [9]Song-lin YU, Wei-yan ZHOU, Rui-yue YANG, Hong-xia LI, Shun-li ZHANG, Tian-jiao ZHANG, Hai-jian ZHAO, Chuan-bao ZHANG, Shu WANG, Wen-xiang CHEN, Jun DONG. Detection of Serum Cholesterol Ester Fatty Acids in the Elderly with Type 2 Diabetes Mellitus[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(3): 264-269. DOI: 10.3969/j.issn.1674-9081.2014.03.004
    [10]Jie HAN, Ke LÜ, Yu-xiu LI, Liang WANG, Qing DAI, Yu-xin JIANG, Zeng-yi LI, Mei-cen ZHOU. Sonographic Quantification of Non-alcoholic Fatty Liver in Patients with Type 2 Diabetes Mellitus and the Association of Its Findings with Biochemical Indicators[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(1): 59-63. DOI: 10.3969/j.issn.1674-9081.2014.01.014

  • Cited by

    Periodical cited type(2)

    1. 赵明曦，孙建华，罗红波，李尊柱，李欣，井杰，张青，吴欣娟，王小亭. 《重症超声临床操作技术的护理规范》解读. 中华现代护理杂志. 2024(05): 584-588 .
    2. 栾诚，郭凡，嵇艳. ICU患者外周动脉导管非计划性拔管风险预测模型的构建及验证. 护理学杂志. 2023(06): 63-67 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (355) PDF downloads (25) Cited by(2)
    Related
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

      Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return
      x Close Forever Close